Charles River Laboratories International (CRL) Other Non-Current Assets (2009 - 2025)
Charles River Laboratories International (CRL) recorded quarterly Other Non-Current Assets of $293.2 million in Q4 2025, up 0.79% quarter-over-quarter from $290.9 million in Q3 2025, and up 5.37% on a YoY basis from $278.2 million in Q4 2024.
Charles River Laboratories International (CRL) Other Non-Current Assets (2009 - 2025) Analysis & Trends
Charles River Laboratories International's Other Non-Current Assets history runs 17 years deep, the most recent figure standing at $293.2 million for Q4 2025.
- In Q4 2025, Other Non-Current Assets rose 5.37% year-over-year to $293.2 million; the TTM figure through Dec 2025 stood at $293.2 million (up 5.37% YoY), while the FY2025 annual figure was $293.2 million, up 5.37% from the prior year.
- Other Non-Current Assets was $293.2 million for Q4 2025 at Charles River Laboratories International, up from $290.9 million in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $435.6 million in Q2 2022 to a low of $148.3 million in Q4 2022.
- Historically, Other Non-Current Assets has averaged $285.4 million across 5 years, with a median of $298.8 million in 2024.
- Biggest YoY gain for Other Non-Current Assets was 108.65% in 2023; the steepest drop was 64.31% in 2023.
- A 5-year view of Other Non-Current Assets shows it stood at $151.5 million in 2021, then retreated by 2.15% to $148.3 million in 2022, then jumped by 108.65% to $309.4 million in 2023, then decreased by 10.07% to $278.2 million in 2024, then climbed by 5.37% to $293.2 million in 2025.
- The last three Other Non-Current Assets figures came in at $293.2 million (Q4 2025), $290.9 million (Q3 2025), and $296.5 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 29,902.70 Bn | 29,902.24 Bn | 1.11 Bn | 498.00 Mn |
| 2 | Thermo Fisher Scientific | 175.99 Bn | 172.74 Bn | 7.74 Bn | 5.97 Bn |
| 3 | Danaher | 129.87 Bn | 124.18 Bn | 3.59 Bn | 4.21 Bn |
| 4 | Idexx Laboratories | 44.75 Bn | 44.55 Bn | 722.74 Mn | 552.79 Mn |
| 5 | Agilent Technologies | 37.52 Bn | 35.72 Bn | 990.00 Mn | 1.18 Bn |
| 6 | Iqvia Holdings | 30.91 Bn | 28.94 Bn | 1.36 Bn | 489.00 Mn |
| 7 | Natera | 30.21 Bn | 29.11 Bn | 696.04 Mn | 51.00 Mn |
| 8 | Illumina | 24.19 Bn | 23.04 Bn | 721.00 Mn | 523.00 Mn |
| 9 | Mettler Toledo International | 23.12 Bn | 23.06 Bn | 555.82 Mn | 454.16 Mn |
| 10 | Charles River Laboratories International | 9.26 Bn | 9.06 Bn | 744.94 Mn | 293.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 27, 2025 | 293.19 Mn |
| Sep 27, 2025 | 290.89 Mn |
| Jun 28, 2025 | 296.46 Mn |
| Mar 29, 2025 | 294.10 Mn |
| Dec 28, 2024 | 278.23 Mn |
| Sep 28, 2024 | 307.01 Mn |
| Jun 29, 2024 | 301.18 Mn |
| Mar 30, 2024 | 303.15 Mn |
| Dec 30, 2023 | 309.38 Mn |
| Sep 30, 2023 | 154.88 Mn |
| Jul 1, 2023 | 155.47 Mn |
| Apr 1, 2023 | 153.99 Mn |
| Dec 31, 2022 | 148.28 Mn |
| Sep 24, 2022 | 429.69 Mn |
| Jun 25, 2022 | 435.64 Mn |
| Mar 26, 2022 | 356.65 Mn |
| Dec 25, 2021 | 151.54 Mn |
| Sep 25, 2021 | 341.45 Mn |
| Jun 26, 2021 | 357.79 Mn |
| Mar 27, 2021 | 349.43 Mn |